Antibodies to mutated citrullinated vimentin and anti-cyclic citrullinated peptide antibodies in inflammatory bowel disease and related arthritis

被引:7
|
作者
Al-Jarallah, Khaled [1 ]
Shehab, Diaa [1 ]
Al-Attiyah, Rajaa [2 ]
Al-Azmi, Waleed [1 ]
Al-Fadli, Ahmad [3 ]
Haider, Mohammed Zafar [4 ]
Panaccione, Remo [5 ]
Ghosh, Subrata [5 ]
机构
[1] Kuwait Univ, Dept Med, Fac Med, Safat 13110, Kuwait
[2] Kuwait Univ, Dept Microbiol, Fac Med, Safat 13110, Kuwait
[3] Mubarak Al Kabeer Hosp, Dept Gastroenterol, Safat, Kuwait
[4] Kuwait Univ, Dept Pediat, Fac Med, Safat 13110, Kuwait
[5] Univ Calgary, Div Med, Fac Med, Calgary, AB T2N 1N4, Canada
关键词
arthritis; anti-cyclic citrullinated peptide antibodies; anti-mutated citrullinated vimentin; inflammatory bowel disease; spondylarthropathies; MUSCULOSKELETAL MANIFESTATIONS; RHEUMATOID-ARTHRITIS; CLASSIFICATION; EPIDEMIOLOGY; PREVALENCE; CCP;
D O I
10.1002/ibd.21937
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Antibodies that react with citrullinated proteins (anti-mutated citrullinated vimentin [anti-MCV] and second-generation anti-cyclic citrullinated peptide antibodies [anti-CCP2]) are markers for rheumatoid arthritis. Recent studies have demonstrated that these antibodies are present in other arthropathies including the spondyloarthritis, psoriatic arthritis, and juvenile idiopathic arthritis. Arthritis associated with inflammatory bowel disease (IBD) takes various forms, with some shared similarities with classic spondylarthropathies. Our objective was to investigate the role of anti-MCV and anti-CCP2 as potential biomarkers in IBD and related arthritis. Methods: In all, 125 IBD patients (71 males, 54 females) were compared to 81 age- and sex-matched healthy controls. Anti-MCV and Anti-CCP2 IgG were measured using an enzyme linked immunosorbent assay. Results: In the 125 IBD patients (mean age 32.6 +/- 12.3 years), 44 (35.2%) had ulcerative colitis and 81 (64.8%) had Crohn's disease. Forty-four (35.2%) IBD patients developed arthritic manifestations. Antibody positivity was observed in 24/125 (19.2%) IBD patients and in 18/81 (22.2%) healthy subjects. The proportion of anti-MCV positivity among IBD patients and healthy individuals were similar: 16.8% vs. 16.0%, P = 0.887. Anti-CCP2 positivity among IBD patients and healthy individuals was also comparable: 6.4% vs. 6.2%, P = 0.948. Similarly, the presence of anti-MCV and anti-CCP2 antibodies was not different among IBD patients with and without arthritis. The mean titers of antibodies were low: anti-MCV (29.6 +/- 7.5 U/mL) and anti-CCP2 (27.6 +/- 4.0 U/mL) in IBD patients with arthritis. Conclusions: Autoantibodies to citrullinated proteins were low in IBD-related arthritis. These findings suggest that these antibodies are not useful biomarkers in IBD to predict who may develop IBD-related arthropathy. (Inflamm Bowel Dis 2012)
引用
收藏
页码:1655 / 1662
页数:8
相关论文
共 50 条
  • [41] Anti-Cyclic Citrullinated Peptide Antibodies in Adult Patients With Juvenile Idiopathic Arthritis
    Skare, Thelma S.
    Nisihara, Renato M.
    Silva, Rafael Mourato
    Munhoz da Silva, Danilo J.
    Gameiro Silva, Marilia B.
    Utiyama, Shirley R. R.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2011, 17 (08) : 421 - 423
  • [42] ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES, WHICH ASSAY FOR THE DIAGNOSIS OF RHEUMATOID ARTHRITIS?
    Debaugnies, F.
    Servais, G.
    Badot, V.
    Noubouossie, D.
    Willems, D.
    Corazza, F.
    [J]. ACTA CLINICA BELGICA, 2012, 67 (01): : 65 - 65
  • [43] Association of anti-cyclic citrullinated peptide and anti-Sa/citrullinated vimentin autoantibodies in rheumatoid arthritis
    Rodriguez-Mahou, Margarita
    Lopez-Longo, Francisco Javier
    Sanchez-Ramon, Silvia
    Estecha, Ana
    Garcia-Segovia, Aurea
    Jost Rodriguez-Molina, Juan
    Carreno, Luis
    Fernandez-Cruz, Eduardo
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2006, 55 (04): : 657 - 661
  • [44] Anti-cyclic citrullinated peptide antibodies in lung diseases associated with rheumatoid arthritis
    Inui, Naoki
    Enomoto, Noriyuki
    Suda, Takafumi
    Kageyama, Yasunori
    Watanabe, Hiroshi
    Chida, Kingo
    [J]. CLINICAL BIOCHEMISTRY, 2008, 41 (13) : 1074 - 1077
  • [45] The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis
    Korendowych, E
    Owen, P
    Ravindran, J
    Carmichael, C
    McHugh, N
    [J]. RHEUMATOLOGY, 2005, 44 (08) : 1056 - 1060
  • [46] Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis
    Anne E Tebo
    Troy Jaskowski
    K Wayne Davis
    April Whiting
    Bronte Clifford
    Andrew Zeft
    Bernadette McNally
    Harry R Hill
    John Bohnsack
    Sampath Prahalad
    [J]. Pediatric Rheumatology, 10
  • [47] Occurence of anti-cyclic citrullinated peptide antibodies in other arthritis than rheumatoid
    Jancelewicz, J.
    Bachta, A.
    Tlustochowicz, M.
    Drabiszczak, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 586 - 586
  • [48] Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis
    Kasapçopur, Ö
    Altun, S
    Aslan, M
    Karaarslan, S
    Kamburoglu-Göksel, A
    Saribas, S
    Arisoy, N
    Kocazeybek, B
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (12) : 1687 - 1689
  • [49] Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis
    Kasapcopur, O
    Altun, S
    Arslan, M
    Karaarslan, S
    Kamburoglu-Goksel, A
    Saribas, S
    Arisoy, N
    Kocazeybek, B
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 80 - 80
  • [50] Ocular manifestations of rheumatoid arthritis and their correlation with anti-cyclic citrullinated peptide antibodies
    Vignesh, Ammapati Paul Pandian
    Srinivasan, Renuka
    [J]. CLINICAL OPHTHALMOLOGY, 2015, 9 : 393 - 397